Literature DB >> 7590675

The effect of prostaglandin E1 on liver adenine nucleotides and cytoplasmic enzymes in a porcine model of normothermic hepatic ischemia.

T S Helling1, B M Wogahn, S A Olson, L S Evans, B R Reddy, C VanWay.   

Abstract

The liver has been judged relatively resistant to ischemia, but prolonged inflow occlusion at normothermic conditions can produce evidence of reversible or irreversible hepatocellular damage. Cytoprotective agents have been used both experimentally and clinically to afford extended viability of hepatocytes under reduced perfusion. One agent, prostaglandin E1, has been described clinically as effective in sustaining liver function under ischemic conditions. We have sought to verify this observation in an experimental model using prolonged normothermic inflow occlusion. Twenty miniature pigs were anesthetized and subjected to subtotal normothermic hepatic inflow occlusion (portal vein, hepatic artery, choledochal vessels) to allow for sufficient splanchnic decompression. Half of the animals received pretreatment with prostaglandin E1 (alprostadil) 500 micrograms intravenously. Inflow occlusion was maintained for 2 hours followed by reperfusion and killing 24 hours later. As a measure of functional preservation, the tissue adenine nucleotides adenosine monophosphate, diphosphate, and triphosphate (AMP, ADP, ATP) were measured in ischemic liver by freeze-clamping and high-performance liquid chromatography during occlusion and after reperfusion. Cytosolic enzyme determinations (aspartate transaminase, alanine transaminase, lactate dehydrogenase) were also made before occlusion and after reperfusion. As a possible indicator of cellular injury, blood ionized Ca++ was measured before inflow occlusion and after reperfusion. Although no difference was found in levels of AMP and ADP between prostaglandin E1 and control animals, ATP levels rose significantly higher during recovery in prostaglandin E1 animals at 60 minutes and 24 hours after reperfusion (13.97 +/- 1.29 and 13.60 +/- 0.91 mumoles/gm dry weight prostaglandin E1 vs. 9.25 +/- 0.97 and 9.80 +/- 0.85 mumoles/gm dry weight co control, P < .01).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7590675

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  5 in total

1.  Molecular basis of protective effect by crocetin on survival and liver tissue damage following hemorrhagic shock.

Authors:  Animesh Dhar; George Cherian; Gopal Dhar; Gibanananda Ray; Ram Sharma; Sushanta K Banerjee
Journal:  Mol Cell Biochem       Date:  2005-10       Impact factor: 3.396

2.  Inhibition of fatty acid synthase with C75 decreases organ injury after hemorrhagic shock.

Authors:  Michael Kuncewitch; Weng Lang Yang; Asha Jacob; Adam Khader; Matthew Giangola; Jeff Nicastro; Gene F Coppa; Ping Wang
Journal:  Surgery       Date:  2015-09-12       Impact factor: 3.982

3.  Attenuation of ischemic liver injury by prostaglandin E1 analogue, misoprostol, and prostaglandin I2 analogue, OP-41483.

Authors:  E Totsuka; S Todo; Y Zhu; N Ishizaki; Y Kawashima; M B Jin; A Urakami; T Shimamura; T E Starzl
Journal:  J Am Coll Surg       Date:  1998-09       Impact factor: 6.113

4.  Effect of short-term administration of prostaglandin E1 on viability after ischemia/reperfusion injury with extended hepatectomy in cirrhotic rat liver.

Authors:  Mohammad Akram Hossain; Kunihiko Izuishi; Hajime Maeta
Journal:  World J Surg       Date:  2003-08-21       Impact factor: 3.352

5.  Efficacy of high-intensity focused ultrasound-assisted hepatic resection (HIFU-AR) on blood loss reduction in patients with liver metastases requiring hepatectomy: study protocol for a randomized controlled trial.

Authors:  Aurélien Dupré; David Pérol; Ellen Blanc; Patrice Peyrat; Valéria Basso; Yao Chen; Jérémy Vincenot; Anthony Kocot; David Melodelima; Michel Rivoire
Journal:  Trials       Date:  2017-02-06       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.